MarkHMirochnickMD

Neonat/Perinatology • Boston, MA

Professor, Pediatrics, Boston University School of Medicine

Join to view full profile

Dr. Mirochnick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mirochnick's full profile

Already have an account?

Office
840 Harrison Ave
Menino 3
Boston, MA 02118
Phone+1 617-414-5471

Fax+1 617-414-4358

Education & Training

University of ConnecticutFellowship, Neonatal-Perinatal Medicine, 1984 - 1986
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1980 - 1983
University of Vermont College of MedicineClass of 1980

Certifications & Licensure

MA State Medical License 1983 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Neonatal-Perinatal Medicine

Clinical Trials

A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.
Completed
Not Applicable
A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women
Completed
Phase 1
A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
Completed
Phase 1
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy Start of enrollment: 2003 Jun 09
Completed
Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies Start of enrollment: 2006 Nov 01
Completed
Phase 1
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission Start of enrollment: 2013 Sep 05
Completed
Phase 4
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection Start of enrollment: 2017 Jun 05
Completed
Phase 1
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum Start of enrollment: 2021 Sep 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

32 citations
Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose.
Mark Mirochnick, Alejandro Dorenbaum, Suzette Blanchard, Coleen K. Cunningham, Richard D. Gelber
Journal of Acquired Immune Deficiency Syndromes. 2003-06-01
5 citations
Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development.
Sherry Zhao, Mary Gockenbach, Manuela Grimstein, Hari Cheryl Sachs, Mark Mirochnick
Frontiers in Pediatrics. 2021-10-13
1226 citations
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomi...
Laura Guay, Philippa Musoke, Thomas Fleming, Danstan Bagenda, Melissa Allen
Lancet. 1999-09-04

Grant Support

Safety Pharmacokinetics &Efficacy Of Artemether &Lumefantrine In Pregnant WomenNational Institute Of Allergy And Infectious Diseases2008
Pharmacokinetics Of Antiretroviral Drugs In Pregnant HIV Infected WomenNational Center For Research Resources2007
Antiretroviral Drugs During PREGNANCY, Substudy Of Pactg P1025National Center For Research Resources2007
Perinatal Core Protocol For HIV Infected Women (Pactg P1025, Version 20)National Center For Research Resources2006–2007
Antiretroviral Drugs During PREGNANCY, HIV Infected Women (Sub Of Pactg P1025)National Center For Research Resources2006
Antiretroviral Pharmacology/Lactating Mother/InfantsEunice Kennedy Shriver National Institute Of Child Health &Human Development2005–2006
Perinatal Core Protocol In HIV Infected Women (Pactg P1025, Version 20)National Center For Research Resources2005
Antiretroviral Drugs During Pregnancy In HIV Positive FemalesNational Center For Research Resources2005
Perinatal Core Protocol (Pactg P1025, Version 2.0)National Center For Research Resources2004
ACTG 316, V 1--Nevirapine Versus Nevirapine Placebo In Pregnant HIV WomenNational Center For Research Resources1999–2001
ACTG 353, V 2--Nelfinavir Coadministered W/ Zidovudine &LamivudineNational Center For Research Resources1999–2000
Recombinant HIV 1 Envelope Antigen In Children Born To HIV Infected MothersNational Center For Research Resources1997–1999
Determinations Of Cannabinoids In MeconiumNational Center For Research Resources1998
Hivig In The Prevention Of Maternal Fetal Transmission Of HIVNational Center For Research Resources1997
Hivig In The Prevention Of Maternal-Fetal Transmission Of HIVNational Center For Research Resources1996
Pharmacokinetics Of Dapsone In ChildrenNational Center For Research Resources1992–1993
Intravenous AZT In Infants With HIVNational Center For Research Resources1991

MarkHMirochnickMD

Dr. Mirochnick is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Grant Support

Viewing the full profile is available to verified healthcare professionals only.